Get started
Author

Agneta Jansson

Observed names: A Jansson, A. Jansson, AGNETA JANSSON, Agneta Jansson Jansson, Agneta K Jansson, Agneta K. Jansson
OpenAlex ID: A5113738045
Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer
2017 · Erik Hilborn, Olle Stål, et al. · Oncotarget · 128
PDF
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study
2006 · B. Iacopetta, A. Russo, et al. · Annals of Oncology · 120
17β-Hydroxysteroid Dehydrogenase 14 Affects Estradiol Levels in Breast Cancer Cells and Is a Prognostic Marker in Estrogen Receptor–Positive Breast Cancer
2006 · Agneta K. Jansson, Cecilia Gunnarsson, et al. · Cancer Research · 74
Bax Expression Decreases Significantly From Primary Tumor to Metastasis in Colorectal Cancer
2002 · Agneta Jansson, Xiao-Feng Sun · Journal of Clinical Oncology · 69
Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer
2016 · Erik Hilborn, Jelena Gacic, et al. · British Journal of Cancer · 55
PDF
Ki‐67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas
1997 · AGNETA JANSSON, XIAO‐FENG SUN · Apmis · 55
YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
2014 · Fredrik Jerhammar, Ann-Charlotte Johansson, et al. · Oral Oncology · 52
17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer
2009 · Agneta Jansson · The Journal of Steroid Biochemistry and Molecular Biology · 51
Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer
2001 · Gunnar Adell, Hong Zhang, et al. · International Journal of Radiation Oncology*Biology*Physics · 38
Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer
2010 · Piiha-Lotta Jerevall, Agneta Jansson, et al. · Breast Cancer Research · 36
PDF
Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer
2007 · Cecilia Gunnarsson, Piiha-Lotta Jerevall, et al. · Breast Cancer Research and Treatment · 35
Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma.
1999 · S Evertsson, Z Bartik, et al. · International Journal of Oncology · 35
Expression Patterns of 17β-Hydroxysteroid Dehydrogenase 14 in Human Tissues
2012 · T. Sivik, S. Vikingsson, et al. · Hormone and Metabolic Research · 34
Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients
2009 · Agneta Jansson, Lovisa Delander, et al. · Clinical Cancer Research · 34
Noxa in colorectal cancer: a study on DNA, mRNA and protein expression
2003 · Agneta K Jansson, Anna M Emterling, et al. · Oncogene · 33
p53 Mutations are present in colorectal cancer with cytoplasmic p53 accumulation
2001 · Agneta Jansson, Massimiliano Gentile, et al. · International Journal of Cancer · 33
PDF
Heat shock protein 72/73 in relation to cytoplasmic p53 expression and prognosis in colorectal adenocarcinomas
1997 · Xiao-Feng Sun, Hong Zhang, et al. · International Journal of Cancer · 26
PDF
C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients
2014 · Erik Hilborn, Tove Sivik, et al. · Breast Cancer Research and Treatment · 24
PDF
Proliferative responses to altered 17β-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors
2006 · A Jansson, C Gunnarsson, et al. · Endocrine Related Cancer · 21
PDF
The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer
2017 · Erik Hilborn, Olle Stål, et al. · Oncotarget · 19
Expression of COX-2 and steroid converting enzymes in breast cancer
2006 · Cecilia Gunnarsson, Agneta Jansson, et al. · Oncology Reports · 19
PDF
Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer
2003 · Agneta Jansson, Gunnar Arbman, et al. · International Journal of Oncology · 19
17β-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer
2012 · Tove Sivik, Cecilia Gunnarsson, et al. · PLoS ONE · 17
PDF
A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer
2007 · Agneta Jansson, Jonas Carlsson, et al. · Breast Cancer Research and Treatment · 12
mRNA and protein expression of PUMA in sporadic colorectal cancer
2004 · Agneta Jansson, Gunnar Arbman, et al. · Oncology Reports · 12
Works count: 42
Citation count: 1,060
H-index: 19
I10-index: 25
Year
Topic
Type